PharmaTimesNews & Politicsnews

Connecta launches phase 2a trial of neuroplasticity modulator

Wednesday, June 10, 2026John PinchingView original

Study marks major milestone for CTH120 as company advances disease‑modifying ambitions

Read the full article on the original site.